United States Biotechnology & Medical Research

Context Therapeutics Inc (CNTX)

Track

The most recent insider trading activity occurred on June 9, 2025, with the Chief Executive Officer purchasing 100,000 shares. Prior to this, on June 6, 2025, the Chief Legal Officer and Chief Financial Officer also made purchases. These transactions represent the latest insider buying activity.
Stock chart
Ticker: CNTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lehr Martin A.
Chief Executive Officer
1 purchase — total 70,080 USD
Buy 9 Jun 2025
Value US$4,802,218.99 | Price 141.88 | Shares 32,890
Buy 6 Jun 2025
Value US$902,376.38 | Price 458.05 | Shares 29,734
Buy 6 Jun 2025
Value US$11,520.00 | Price 0.58 | Shares 20,000
Planned buy 21 Feb 2023
Value US$4,900.05 | Price 0.84 | Shares 5,823
Planned buy 13 Feb 2023
Value US$4,900.77 | Price 0.87 | Shares 5,606
Planned buy 6 Feb 2023
Value US$4,900.39 | Price 0.97 | Shares 5,040
Planned buy 30 Jan 2023
Value US$4,900.63 | Price 0.70 | Shares 7,027
Planned buy 23 Jan 2023
Value US$4,900.83 | Price 0.72 | Shares 6,839
Planned buy 17 Jan 2023
Value US$4,995.00 | Price 0.74 | Shares 6,783
Buy 16 Dec 2022
Value US$14,796.00 | Price 0.74 | Shares 20,000
Buy 16 Dec 2022
Value US$18,500.00 | Price 0.74 | Shares 25,000
Buy 9 Dec 2022
Value US$5,094.60 | Price 0.85 | Shares 6,000
Buy 19 Aug 2022
Value US$24,064.30 | Price 1.85 | Shares 13,000
Buy 17 Aug 2022
Value US$27,000.00 | Price 1.80 | Shares 15,000
Buy 16 Aug 2022
Value US$19,500.00 | Price 1.95 | Shares 10,000
Buy 16 Dec 2021
Value US$41,849.60 | Price 3.22 | Shares 13,000
Buy 22 Oct 2021
Value US$15,000.00 | Price 5.00 | Shares 3,000
Buy 22 Oct 2021
Value US$50,000.00 | Price 5.00 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-10 2025-06-09 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
32,890 -26.7%
141.88
US$4,802,219 		32,890 -26.7% 141.88 US$4,802,219
2025-06-10 2025-06-06 B Purchase
2.3
Minai-Azary Jennifer Lynn

Chief Financial Officer

Officer
29,734 -15.3%
458.05
US$902,376 		29,734 -15.3% 458.05 US$902,376
2025-06-10 2025-06-06 B Purchase
3.3
Levit Alex C.

Chief Legal Officer, Corp. Sec

Officer
11,028 +47.9%
190.36
US$801,276 		11,028 +47.9% 190.36 US$801,276
2023-02-21 2023-02-21 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
5,823 +3.8%
0.84
US$4,900 		5,823 +3.8% 0.84 US$4,900
2023-02-13 2023-02-13 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
5,606 +3.8%
0.87
US$4,901 		5,606 +3.8% 0.87 US$4,901
2023-02-06 2023-02-06 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
5,040 +3.5%
0.97
US$4,900 		5,040 +3.5% 0.97 US$4,900
2023-01-30 2023-01-30 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
7,027 +5.2%
0.70
US$4,901 		7,027 +5.2% 0.70 US$4,901
2023-01-23 2023-01-23 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
6,839 +5.3%
0.72
US$4,901 		6,839 +5.3% 0.72 US$4,901
2023-01-18 2023-01-17 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
6,783 +5.5%
0.74
US$4,995 		6,783 +5.5% 0.74 US$4,995
2022-12-19 2022-12-16 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
20,000 +19.5%
0.74
US$14,796 		20,000 +19.5% 0.74 US$14,796
2022-12-19 2022-12-16 B Purchase
2.3
Minai-Azary Jennifer Lynn

Chief Financial Officer

Officer
25,000 +166.7%
0.74
US$18,500 		25,000 +166.7% 0.74 US$18,500
2022-12-12 2022-12-09 B Purchase
3.3
Levit Alex C.

Chief Legal Officer, Corp. Sec

Officer
6,000 +200.0%
0.85
US$5,095 		6,000 +200.0% 0.85 US$5,095
2022-08-22 2022-08-19 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
13,000 +14.5%
1.85
US$24,064 		13,000 +14.5% 1.85 US$24,064
2022-08-17 2022-08-17 B Purchase
2.3
Minai-Azary Jennifer Lynn

Chief Financial Officer

Officer
15,000 +inf%
1.80
US$27,000 		15,000 +inf% 1.80 US$27,000
2022-08-17 2022-08-16 B Purchase
0.5
Sahmoud Tarek

Chief Medical Officer

Officer
10,000 +inf%
1.95
US$19,500 		10,000 +inf% 1.95 US$19,500
2021-12-20 2021-12-16 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
13,000 +1.6%
3.22
US$41,850 		13,000 +1.6% 3.22 US$41,850
2021-10-25 2021-10-22 B Purchase
3.3
Levit Alex C.

Chief Legal Officer, Corp. Sec

Officer
3,000 +inf%
5.00
US$15,000 		3,000 +inf% 5.00 US$15,000
2021-10-25 2021-10-22 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
10,000 +11.2%
5.00
US$50,000 		10,000 +11.2% 5.00 US$50,000
Explore more

More insider trading research around Context Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America